ReviewFrontiers in reproductive health2025
Endometrial hypoperfusion: the missing link in refractory thin endometrium.
Review in Frontiers in reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Platelet-Rich Plasma in Recurrent Pregnancy Loss: Toward a Precision Medicine Framework for Biologically Guided Patient Selection.Medical sciences (Basel, Switzerland) · 2026Review
- Optimizing the Endometrial Factor in Recurrent Implantation Failure: From Established Diagnostics to Mechanism-Informed Management.Journal of clinical medicine · 2026Review
- How endometrial thickness affects pregnancy and perinatal outcomes: a retrospective study of 16,566 frozen-thawed single blastocyst transfer cycles.Reproductive biology and endocrinology : RB&E · 2026Article
- The Role of Granulocyte Colony-Stimulating Factor in Endometrial Preparation for Embryo Implantation in In Vitro Fertilization.Life (Basel, Switzerland) · 2026Review
- Endometrial dysfunction in embryo implantation: from molecular mechanisms to clinical management.Frontiers in reproductive health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistently thin endometrium remains one of the hardest challenges in reproductive medicine, often linked to implantation failure and poor pregnancy outcome. Growing evidence implicates deficient uterine blood supply in the pathogenesis of an inadequately thin endometrial lining. This narrative review synthesizes current knowledge on how endometrial vascularization influences endometrial thickness (EMT) and receptivity. We outline the normal endometrial structure and vascular physiology, then examine the pathophysiological features of thin endometrium, highlighting mechanistic studies that demonstrate impaired angiogenesis, reduced microvessel density, and tissue hypoxia in thin endometrial tissue. Doppler ultrasound studies consistently show that women with thin endometrium have reduced endometrial and subendometrial blood flow and higher resistance indices. Clinical correlations indicate that poor endometrial perfusion is associated with lower implantation and pregnancy rates in assisted reproduction. We review diagnostic tools for assessing endometrial perfusion, including two-dimensional (2D) and three-dimensional (3D) Doppler ultrasound measures of uterine and subendometrial blood flow. Therapeutic strategies aiming to improve uterine blood supply, such as vasoactive medications, intrauterine infusion of platelet-rich plasma (PRP), stem cell therapies, and other angiogenic treatments, often result in a marginal improvement of EMT and pregnancy outcomes. While these interventions show promise, limitations include small sample sizes and heterogeneous study designs. We discuss future directions, emphasizing the need for larger trials and a deeper understanding of angiogenic signaling in the endometrium. In conclusion, converging evidence supports poor endometrial blood supply as a key contributor to persistently thin endometrium. Future therapies that specifically target enhancement of endometrial blood supply may prove to be effective tools for improving endometrial growth and fertility outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.